Avg closing price
Price range

27 Cathie Wood Intellia Therapeutics Trades

Cathie Wood acquired 11.4 Million Intellia Therapeutics shares worth $310 Million. That's 1.97% of their equity portfolio (17th largest holding). The investor owns 12.17% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares twenty more times and sold shares on six occasions. The investor's estimated purchase price is $397 Million, resulting in a loss of 22%.

Avg closing price
Price range
Increased shares by 14.7% (+1.46 Million shares) Q4 2023
Avg closing price $28.74
Price range $23.16 - $32.34
Increased shares by 4.4% (+423 Thousand shares) Q3 2023
Avg closing price $38.80
Price range $31.62 - $45.78
Sold 3.2% shares (-311 Thousand shares) Q2 2023
Avg closing price $40.55
Price range $34.58 - $46.03
Increased shares by 4.4% (+416 Thousand shares) Q1 2023
Avg closing price $39.22
Price range $33.30 - $44.82
Sold 2.4% shares (-236 Thousand shares) Q4 2022
Avg closing price $47.55
Price range $33.21 - $62.69
Increased shares by 1.5% (+142 Thousand shares) Q3 2022
Avg closing price $62.04
Price range $53.92 - $71.70
Increased shares by 5.9% (+534 Thousand shares) Q2 2022
Avg closing price $50.78
Price range $38.49 - $76.21
Increased shares by 13.4% (+1.06 Million shares) Q1 2022
Avg closing price $84.72
Price range $58.27 - $118.99
Increased shares by 17.4% (+1.17 Million shares) Q4 2021
Avg closing price $125.27
Price range $100.76 - $138.36
Sold 12.2% shares (-941 Thousand shares) Q3 2021
Avg closing price $151.40
Price range $132.37 - $176.78
Sold 20.1% shares (-1.93 Million shares) Q2 2021
Avg closing price $77.87
Price range $60.88 - $161.91
Sold 14.1% shares (-1.58 Million shares) Q1 2021
Avg closing price $67.12
Price range $46.59 - $83.68
Sold 1.9% shares (-213 Thousand shares) Q4 2020
Avg closing price $36.31
Price range $18.83 - $63.53
Increased shares by 0.0% (+1.37 Thousand shares) Q3 2020
Avg closing price $20.85
Price range $17.47 - $24.93
Increased shares by 11.4% (+1.16 Million shares) Q2 2020
Avg closing price $16.99
Price range $11.14 - $22.87
Increased shares by 17.1% (+1.5 Million shares) Q1 2020
Avg closing price $13.47
Price range $9.44 - $15.58
Increased shares by 9.5% (+760 Thousand shares) Q4 2019
Avg closing price $13.91
Price range $10.43 - $17.67
Increased shares by 17.3% (+1.18 Million shares) Q1 2019
Avg closing price $14.91
Price range $12.79 - $17.62
Increased shares by 18.2% (+1.05 Million shares) Q4 2018
Avg closing price $18.59
Price range $11.39 - $27.13
Increased shares by 27.5% (+1.24 Million shares) Q3 2018
Avg closing price $29.09
Price range $25.78 - $32.60

News about Intellia Therapeutics Inc and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!